Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Sales | 989 | 1,209 | 838 | 637 | 432 |
| Gross Profit | 989 | 1,209 | 838 | 637 | 440 |
| Operating Expenses | 4,941 | 4,969 | 4,843 | 3,242 | 3,270 |
| Operating Income | -3,952 | -3,760 | -4,005 | -2,605 | -2,838 |
| Interest Expense | 383 | -47 | 0 | 0 | 0 |
| Other Income | -553 | -876 | -929 | -585 | -682 |
| Pre-tax Income | -4,887 | -4,589 | -4,934 | -3,190 | -3,520 |
| Net Income Continuous | -4,887 | -4,589 | -4,934 | -3,190 | -3,499 |
| Net Income | $-4,887 | $-4,589 | $-4,934 | $-3,190 | $-3,499 |
| EPS Basic Total Ops | -1.52 | -1.60 | -2.16 | -1.60 | -1.92 |
| EPS Basic Continuous Ops | -1.66 | -1.59 | -2.15 | -1.48 | -1.81 |
| EPS Diluted Total Ops | -1.52 | -1.60 | -2.16 | -1.60 | -1.92 |
| EPS Diluted Continuous Ops | -1.66 | -1.59 | -2.15 | -1.48 | -1.81 |
| EBITDA(a) | $-3,952 | $-3,584 | $-3,866 | $-2,487 | $-2,838 |